Partner 01
Vivasor
Biopharmaceutical & Funding Partner
A clinical-stage biopharmaceutical holding company working with JP3E to accelerate Korean market entry, strategic development, and long-term platform value creation.
- Appointed JP3E Development Corp. as its exclusive strategic representative and business development agent in the Republic of Korea.
- Advances Korean opportunities spanning licensing, commercialization, manufacturing, research, strategic investment, corporate development, and institutional relationships.
- Connects with qualified Korean counterparties through JP3E while definitive transactions remain directly negotiated and executed by Vivasor and the relevant third parties.
- Serves as a funding partner supporting K2Global’s strategic platform development and market-expansion initiatives.